View in English  English

Cantrell Named U.S. Distributor for Lonza Microbial Control Products

Cantrell will distribute sanitizer system to meat and poultry plants

GAINESVILLE, Ga. (Nov. 8, 2011) – Cantrell, a poultry and food processing equipment, sales and service company, has formed an alliance with Lonza Microbial Control Products to distribute a sanitizer system for meat and poultry plants in the United States.

Cantrell will distribute DryTec® FG sanitizer briquettes along with the MC4 series feeding systems, both of which are provided by Lonza Microbial Control’s Industrial, Commercial and Municipal (ICM) Water Treatment business, which was formerly part of Arch Chemicals.  

“This is a natural complement to our extensive line of food and poultry processing equipment,” said Tony Rice, Cantrell General Manager Finance/Operations. “Hygiene is a critical part of the processing industry. DryTec® FG calcium hypochlorite briquettes are a fast-acting sanitizer and a powerful germicide capable of controlling pathogens in meat and poultry plants.”

These briquettes are a high-concentration chlorine source and, when mixed with water, become an excellent surface sanitizer. The feeding systems come pre-plumbed and skid-mounted for easy installation, and feature patented spray technology for maximum coverage and sanitation. 

Cantrell leads the way in creating and supplying innovative solutions in the poultry industry to customers worldwide.  With an experienced and dedicated staff, Cantrell is focused on providing the best products, parts, and service to poultry processors around the globe.  For more information, please contact Cantrell at 800-922-1232, 770-536-3611, or visit the website at  

Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also the world leader in microbial control providing innovative, chemistry-based and related solutions to destroy or to selectively inhibit the growth of harmful microorganisms. Its activities encompass the areas of water treatment, personal care, health and hygiene, industrial preservation, materials protection, and wood treatment. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition and agro markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange and secondary listed on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza is not subject to the SGX-ST’s continuing listing requirements. Lonza is subject to the listing rules of the SIX Swiss Exchange, which do not have specific requirements equivalent to the listing rules of the SGX-ST in respect of interested person transactions, acquisition and realizations, and delisting. In 2010, the company had sales of CHF 2.680 billion. Further information can be found at